Kojima K, Amemiya S
Medicinal Chemistry Research Laboratory, Sankyo Co., Ltd., Tokyo, Japan.
Chem Pharm Bull (Tokyo). 1993 May;41(5):913-8. doi: 10.1248/cpb.41.913.
3-Oxa-5-methyleneisocarbacyclin (14a) and 3-oxa-5-ethylideneisocarbacyclin (19a) were synthesized. Compound 14a showed a potent antiplatelet aggregating activity, whereas 19a was inactive.
合成了3-氧杂-5-亚甲基异环前列腺素(14a)和3-氧杂-5-亚乙基异环前列腺素(19a)。化合物14a表现出强大的抗血小板聚集活性,而19a则无活性。